Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization

This publication has 30 references indexed in Scilit:

• Characteristics and management of diabetic patients hospitalized for myocardial infarction in France
  Diabetes & Metabolism, 2010
• Trends in adherence to secondary prevention medications in elderly post‐myocardial infarction patients
  Pharmacoepidemiology and Drug Safety, 2008
• Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease
  American Heart Journal, 2008
• Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction
  Circulation, 2008
• Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up
  Interactive CardioVascular and Thoracic Surgery, 2007
• Use of statins and beta-blockers after acute myocardial infarction according to income and education
  Journal of Epidemiology and Community Health, 2007
• Parabolas of medication use and discontinuation after myocardial infarction—are we closing the treatment gap?
  Pharmacoepidemiology and Drug Safety, 2007
• Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study
  BMJ, 2006
• Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease
  Circulation, 2006
• Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
  American Heart Journal, 2005